KIFC1 | kinesin family member C1 | 6p21.32 | 0.602 | 0.782 | 0
|
CCNE2 | cyclin E2 | 8q22.1 | 0.571 | 0.713 | 0
|
MCM2 | minichromosome maintenance complex component 2 | 3q21 | 0.568 | 0.75 | 0
|
CHAF1B | chromatin assembly factor 1, subunit B (p60) | 21q22.2 | 0.561 | 0.756 | 0
|
ZNF367 | zinc finger protein 367 | 9q22 | 0.561 | 0.756 | 0
|
ASF1B | anti-silencing function 1B histone chaperone | 19p13.12 | 0.553 | 0.717 | 0
|
CDCA5 | cell division cycle associated 5 | 11q13.1 | 0.549 | 0.656 | 0
|
MELK | maternal embryonic leucine zipper kinase | 9p13.1 | 0.547 | 0.743 | 0
|
NDC80 | NDC80 kinetochore complex component | 18p11.31 | 0.544 | 0.703 | 0
|
TPX2 | TPX2, microtubule-associated | 20q11.2 | 0.544 | 0.705 | 0
|
WDR76 | WD repeat domain 76 | 15q15.3 | 0.541 | 0.758 | 0
|
FEN1 | flap structure-specific endonuclease 1 | 11q12 | 0.537 | 0.683 | 0
|
MCM6 | minichromosome maintenance complex component 6 | 2q14-q21 | 0.537 | 0.76 | 0
|
TYMS | thymidylate synthetase | 18p11.31-p11.21 | 0.536 | 0.723 | 0
|
NCAPG2 | non-SMC condensin II complex, subunit G2 | 7q36.3 | 0.532 | 0.716 | 0
|
DTL | denticleless E3 ubiquitin protein ligase homolog (Drosophila) | 1q32 | 0.529 | 0.704 | 0
|
E2F1 | E2F transcription factor 1 | 20q11 | 0.529 | 0.735 | 0
|
NCAPG | non-SMC condensin I complex, subunit G | 4p15.32 | 0.522 | 0.651 | 0
|
FAM111B | family with sequence similarity 111, member B | 11q12.1 | 0.522 | 0.712 | 0
|
RFC4 | replication factor C (activator 1) 4, 37kDa | 3q27 | 0.521 | 0.725 | 0
|
CENPA | centromere protein A | 2p23.3 | 0.52 | 0.693 | 0
|
DSN1 | DSN1 homolog, MIS12 kinetochore complex component | 20q11.23 | 0.519 | 0.686 | 0
|
KIF4A | kinesin family member 4A | Xq13.1 | 0.518 | 0.695 | 0
|
PRC1 | protein regulator of cytokinesis 1 | 15q26.1 | 0.515 | 0.687 | 0
|
CDKN3 | cyclin-dependent kinase inhibitor 3 | 14q22 | 0.511 | 0.664 | 0
|
USP1 | ubiquitin specific peptidase 1 | 1p31.3 | 0.51 | 0.699 | 0
|
ORC1 | origin recognition complex, subunit 1 | 1p32 | 0.51 | 0.662 | 0
|
MYBL2 | v-myb avian myeloblastosis viral oncogene homolog-like 2 | 20q13.1 | 0.51 | 0.655 | 0
|
CENPI | centromere protein I | Xq22.1 | 0.509 | 0.697 | 0
|
FOXM1 | forkhead box M1 | 12p13 | 0.507 | 0.698 | 0
|
GINS1 | GINS complex subunit 1 (Psf1 homolog) | 20p11.21 | 0.507 | 0.634 | 0
|
PRIM1 | primase, DNA, polypeptide 1 (49kDa) | 12q13.3 | 0.505 | 0.687 | 0
|
CDC6 | cell division cycle 6 | 17q21.3 | 0.5 | 0.626 | 0
|
CDCA8 | cell division cycle associated 8 | 1p34.3 | 0.5 | 0.656 | 0
|
DONSON | downstream neighbor of SON | 21q22.1 | 0.499 | 0.696 | 0
|
RAD51AP1 | RAD51 associated protein 1 | 12p13.2-p13.1 | 0.496 | 0.651 | 0
|
WDR62 | WD repeat domain 62 | 19q13.12 | 0.494 | 0.678 | 0
|
ZWINT | ZW10 interacting kinetochore protein | 10q21-q22 | 0.485 | 0.649 | 0
|
TEX30 | testis expressed 30 | 13q33.1 | 0.481 | 0.704 | 0
|
PCNA | proliferating cell nuclear antigen | 20p13-p12.3 | 0.48 | 0.683 | 0
|
KIF23 | kinesin family member 23 | 15q23 | 0.479 | 0.645 | 0
|
DEK | DEK proto-oncogene | 6p23 | 0.479 | 0.647 | 0
|
EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 7q35-q36 | 0.475 | 0.666 | 0
|
POLE2 | polymerase (DNA directed), epsilon 2, accessory subunit | 14q21-q22 | 0.472 | 0.657 | 0
|
CDC7 | cell division cycle 7 | 1p22 | 0.47 | 0.604 | 0
|
GINS2 | GINS complex subunit 2 (Psf2 homolog) | 16q24.1 | 0.467 | 0.592 | 0
|
PSMC3IP | PSMC3 interacting protein | 17q21.2 | 0.46 | 0.589 | 0
|
IQGAP3 | IQ motif containing GTPase activating protein 3 | 1q21.3 | 0.457 | 0.616 | 0
|
MSH6 | mutS homolog 6 | 2p16 | 0.453 | 0.664 | 0
|
GMPS | guanine monophosphate synthase | 3q25.31 | 0.448 | 0.647 | 0
|
H2AFV | H2A histone family, member V | 7p13 | 0.444 | 0.584 | 0
|
HMGB2 | high mobility group box 2 | 4q31 | 0.443 | 0.578 | 0
|
TMPO-AS1 | TMPO antisense RNA 1 | 12q23.1 | 0.435 | 0.596 | 0
|
PRIM2 | primase, DNA, polypeptide 2 (58kDa) | 6p12-p11.1 | 0.433 | 0.659 | 0
|
C5orf34 | chromosome 5 open reading frame 34 | 5p12 | 0.426 | 0.582 | 0
|
LRR1 | leucine rich repeat protein 1 | 14q21.3 | 0.422 | 0.618 | 0
|
MDC1 | mediator of DNA-damage checkpoint 1 | 6p21.3 | 0.413 | 0.614 | 0
|
PAQR4 | progestin and adipoQ receptor family member IV | 16p13 | 0.412 | 0.622 | 0
|
RIBC2 | RIB43A domain with coiled-coils 2 | 22q13.3 | 0.403 | 0.547 | 0
|
TMEM106C | transmembrane protein 106C | 12q13.1 | 0.401 | 0.635 | 0
|
CENPU | centromere protein U | 4q35.1 | 0.401 | 0.581 | 0
|
CDC25B | cell division cycle 25B | 20p13 | 0.394 | 0.56 | 0
|
C9orf40 | chromosome 9 open reading frame 40 | 9q21.31 | 0.389 | 0.588 | 0
|
CDK2 | cyclin-dependent kinase 2 | 12q13 | 0.381 | 0.561 | 0
|
FBXO45 | F-box protein 45 | 3q29 | 0.381 | 0.551 | 0
|
TFDP1 | transcription factor Dp-1 | 13q34 | 0.375 | 0.578 | 0
|
GPR19 | G protein-coupled receptor 19 | 12p12.3 | 0.373 | 0.577 | 0
|
SKA2 | spindle and kinetochore associated complex subunit 2 | 17q23.2 | 0.373 | 0.574 | 0
|
FANCE | Fanconi anemia, complementation group E | 6p21.31 | 0.359 | 0.585 | 0
|
CBR4 | carbonyl reductase 4 | 4q32.3 | 0.348 | -0.497 | 0
|
CCDC109B | coiled-coil domain containing 109B | 4q25 | 0.341 | 0.533 | 0
|
OXCT1 | 3-oxoacid CoA transferase 1 | 5p13 | 0.333 | 0.457 | 0
|
RB1 | retinoblastoma 1 | 13q14.2 | 0.327 | -0.259 | 6.31e-08
|
PXMP2 | peroxisomal membrane protein 2, 22kDa | 12q24 | 0.326 | 0.565 | 0
|
MORC4 | MORC family CW-type zinc finger 4 | Xq22.3 | 0.325 | 0.532 | 0
|
CCHCR1 | coiled-coil alpha-helical rod protein 1 | 6p21.3 | 0.324 | 0.563 | 0
|
CDKN2B-AS1 | CDKN2B antisense RNA 1 | 9p21.3 | 0.324 | 0.474 | 0
|
CDKN2A | cyclin-dependent kinase inhibitor 2A | 9p21 | 0.322 | 0.437 | 0
|
GPX2 | glutathione peroxidase 2 | 14q23.3 | 0.317 | -0.472 | 0
|
NRM | nurim (nuclear envelope membrane protein) | 6p21.3 | 0.315 | 0.581 | 0
|
TBCCD1 | TBCC domain containing 1 | 3q27.3 | 0.311 | 0.427 | 0
|
OTULIN | OTU deubiquitinase with linear linkage specificity | 5p15.2 | 0.305 | 0.493 | 0
|
RPL3 | ribosomal protein L3 | 22q13 | 0.303 | -0.519 | 0
|
ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 | 6p21.33 | 0.303 | 0.505 | 0
|
TPT1 | tumor protein, translationally-controlled 1 | 13q14 | 0.301 | -0.507 | 0
|
NSG1 | | | 0.301 | -0.374 | 1.21e-15
|
HIST1H2BJ | histone cluster 1, H2bj | 6p22.1 | 0.3 | 0.541 | 0
|
FAM219B | family with sequence similarity 219, member B | 15q23 | 0.3 | -0.443 | 0
|
KIAA0141 | KIAA0141 | 5q31 | 0.299 | -0.408 | 0
|
GLO1 | glyoxalase I | 6p21.3-p21.1 | 0.297 | 0.513 | 0
|
RPN1 | ribophorin I | 3q21.3 | 0.295 | 0.501 | 0
|
HSCB | HscB mitochondrial iron-sulfur cluster co-chaperone | 22q12.1 | 0.295 | -0.321 | 1.33e-11
|
RBBP7 | retinoblastoma binding protein 7 | Xp22.22 | 0.294 | 0.453 | 0
|
KLHL3 | kelch-like family member 3 | 5q31 | 0.293 | -0.444 | 0
|
STK36 | serine/threonine kinase 36 | 2q35 | 0.291 | -0.343 | 4.23e-13
|
CYP20A1 | cytochrome P450, family 20, subfamily A, polypeptide 1 | 2q33 | 0.287 | -0.453 | 0
|
CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 1p32.3 | 0.286 | 0.509 | 0
|
SMIM1 | small integral membrane protein 1 (Vel blood group) | 1p36.32 | 0.285 | -0.46 | 0
|
PIGX | phosphatidylinositol glycan anchor biosynthesis, class X | 3q29 | 0.284 | 0.481 | 0
|
METTL4 | methyltransferase like 4 | 18p11.31 | 0.282 | 0.382 | 1.15e-16
|
TUBG1 | tubulin, gamma 1 | 17q21.31 | 0.281 | 0.473 | 0
|
WDR53 | WD repeat domain 53 | 3q29 | 0.281 | 0.502 | 0
|
TRIM13 | tripartite motif containing 13 | 13q14 | 0.28 | -0.434 | 0
|
ZNF385A | zinc finger protein 385A | 12q13.13 | 0.278 | -0.401 | 0
|
LOC81691 | | | 0.277 | 0.413 | 0
|
SNRPC | small nuclear ribonucleoprotein polypeptide C | 6p21 | 0.276 | 0.486 | 0
|
ANXA3 | annexin A3 | 4q21.21 | 0.276 | 0.402 | 0
|
PTPN2 | protein tyrosine phosphatase, non-receptor type 2 | 18p11.3-p11.2 | 0.275 | 0.276 | 7.92e-09
|
SLFN11 | schlafen family member 11 | 17q12 | 0.274 | 0.385 | 3.09e-17
|
TRIB3 | tribbles pseudokinase 3 | 20p13-p12.2 | 0.272 | 0.399 | 0
|
MICB | MHC class I polypeptide-related sequence B | 6p21.3 | 0.272 | 0.493 | 0
|
KIAA1841 | KIAA1841 | 2p15 | 0.271 | 0.458 | 0
|
C6orf106 | chromosome 6 open reading frame 106 | 6p21.31 | 0.271 | 0.46 | 0
|
DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | 3q27 | 0.271 | 0.463 | 0
|
DERA | deoxyribose-phosphate aldolase (putative) | 12p12.3 | 0.269 | 0.462 | 0
|
LINC00174 | long intergenic non-protein coding RNA 174 | 7q11.21 | 0.268 | -0.279 | 5.09e-09
|
UBE2A | ubiquitin-conjugating enzyme E2A | Xq24 | 0.268 | 0.468 | 0
|
ATG3 | autophagy related 3 | 3q13.2 | 0.268 | 0.388 | 0
|
RPL4 | ribosomal protein L4 | 15q22 | 0.266 | -0.421 | 0
|
LSM2 | LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated | 6p21.3 | 0.266 | 0.5 | 0
|
SLC1A4 | solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | 2p15-p13 | 0.264 | 0.458 | 0
|
ABHD8 | abhydrolase domain containing 8 | 19p13.12 | 0.263 | 0.332 | 2.58e-12
|
EPHX2 | epoxide hydrolase 2, cytoplasmic | 8p21 | 0.263 | -0.462 | 0
|
GAS5 | growth arrest-specific 5 (non-protein coding) | 1q25.1 | 0.263 | -0.35 | 1.36e-13
|
MRPS10 | mitochondrial ribosomal protein S10 | 6p21.1 | 0.26 | 0.447 | 0
|
SHROOM3 | shroom family member 3 | 4q21.1 | 0.258 | 0.314 | 4.31e-11
|
CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 9p21 | 0.257 | 0.326 | 6.42e-12
|
TAF11 | TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa | 6p21 | 0.256 | 0.482 | 0
|
CLPTM1L | CLPTM1-like | 5p15.33 | 0.255 | 0.455 | 0
|
BCL6 | B-cell CLL/lymphoma 6 | 3q27 | 0.253 | -0.358 | 3.17e-14
|
FN3KRP | fructosamine 3 kinase related protein | 17q25.3 | 0.253 | 0.446 | 0
|
TERF2IP | telomeric repeat binding factor 2, interacting protein | 16q23.1 | 0.252 | -0.364 | 9.38e-15
|
HMG20A | high mobility group 20A | 15q24 | 0.252 | -0.307 | 1.07e-10
|
NDNF | neuron-derived neurotrophic factor | 4q27 | 0.252 | -0.437 | 0
|
BTBD11 | BTB (POZ) domain containing 11 | 12q24.11 | 0.251 | -0.179 | 0.000203
|
C6orf163 | chromosome 6 open reading frame 163 | 6q15 | 0.25 | -0.35 | 1.31e-13
|
HMGN2P46 | high mobility group nucleosomal binding domain 2 pseudogene 46 | 15q15.1 | 0.25 | 0.429 | 0
|
FAF1 | Fas (TNFRSF6) associated factor 1 | 1p32.3 | 0.249 | 0.369 | 3.3e-15
|
RPS23 | ribosomal protein S23 | 5q14.2 | 0.249 | -0.354 | 6.25e-14
|
RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 11q23 | 0.249 | 0.2 | 3.13e-05
|
FAM81A | family with sequence similarity 81, member A | 15q22.2 | 0.249 | 0.293 | 8.31e-10
|
GTF2H4 | general transcription factor IIH, polypeptide 4, 52kDa | 6p21.3 | 0.249 | 0.53 | 0
|
SPRYD7 | SPRY domain containing 7 | 13q14.3 | 0.248 | -0.162 | 0.000776
|
ZDHHC14 | zinc finger, DHHC-type containing 14 | 6q25.3 | 0.248 | 0.284 | 2.61e-09
|
ZMYND10 | zinc finger, MYND-type containing 10 | 3p21.3 | 0.248 | 0.332 | 2.49e-12
|
FASTKD3 | FAST kinase domains 3 | 5p15.31 | 0.247 | 0.387 | 0
|
CXCL14 | chemokine (C-X-C motif) ligand 14 | 5q31 | 0.247 | -0.395 | 0
|
GNB2L1 | guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 | 5q35.3 | 0.246 | -0.316 | 3.23e-11
|
NELFE | negative elongation factor complex member E | 6p21.3 | 0.246 | 0.437 | 0
|
RPA2 | replication protein A2, 32kDa | 1p35 | 0.245 | 0.31 | 7.83e-11
|
EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 6q14.1 | 0.243 | -0.424 | 0
|
DIS3L2 | DIS3 like 3'-5' exoribonuclease 2 | 2q37.1 | 0.243 | -0.358 | 3.02e-14
|
ABHD3 | abhydrolase domain containing 3 | 18q11.1 | 0.24 | 0.382 | 1.35e-16
|
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 22q13.1 | 0.24 | -0.266 | 2.62e-08
|
TOP1MT | topoisomerase (DNA) I, mitochondrial | 8q24.3 | 0.239 | -0.311 | 6.7e-11
|
OSR2 | odd-skipped related transciption factor 2 | 8q22.2 | 0.236 | 0.161 | 0.000883
|
TMEM14B | transmembrane protein 14B | 6p25.1-p23 | 0.235 | 0.386 | 0
|
FAM65A | family with sequence similarity 65, member A | 16q22.1 | 0.234 | -0.183 | 0.000143
|
BRPF3 | bromodomain and PHD finger containing, 3 | 6p21.31 | 0.234 | 0.291 | 1.02e-09
|
PROM1 | prominin 1 | 4p15 | 0.233 | -0.105 | 0.0306
|
EIF3L | eukaryotic translation initiation factor 3, subunit L | 22q | 0.232 | -0.447 | 0
|
F8A1 | coagulation factor VIII-associated 1 | Xq28 | 0.23 | 0.445 | 0
|
NUDT15 | nudix (nucleoside diphosphate linked moiety X)-type motif 15 | 13q14.12 | 0.229 | 0.034 | 0.479
|
FAM89A | family with sequence similarity 89, member A | 1q42.2 | 0.229 | -0.167 | 0.000526
|
MTCH1 | mitochondrial carrier 1 | 6p21.2 | 0.229 | 0.365 | 7.8e-15
|
LOC100129534 | | | 0.229 | -0.165 | 0.00063
|
TM2D3 | TM2 domain containing 3 | 15q26.3 | 0.228 | -0.287 | 1.83e-09
|
YY1AP1 | YY1 associated protein 1 | 1q22 | 0.228 | 0.249 | 2.16e-07
|
RPL5 | ribosomal protein L5 | 1p22.1 | 0.227 | -0.331 | 3.06e-12
|
CCND3 | cyclin D3 | 6p21 | 0.227 | 0.325 | 7.69e-12
|
APCDD1 | adenomatosis polyposis coli down-regulated 1 | 18p11.21 | 0.226 | -0.372 | 1.76e-15
|
RNF5 | ring finger protein 5, E3 ubiquitin protein ligase | 6p21.31 | 0.225 | 0.267 | 2.48e-08
|
CABLES2 | Cdk5 and Abl enzyme substrate 2 | 20q13.33 | 0.225 | 0.381 | 2.07e-16
|
PAPD7 | PAP associated domain containing 7 | 5p15 | 0.224 | 0.353 | 8.18e-14
|
PP7080 | | | 0.223 | 0.3 | 3.18e-10
|
FLOT1 | flotillin 1 | 6p21.3 | 0.223 | 0.188 | 9.59e-05
|
SDHA | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) | 5p15 | 0.222 | 0.359 | 2.62e-14
|
SLFN13 | schlafen family member 13 | 17q12 | 0.219 | 0.343 | 4.55e-13
|
FAM210B | family with sequence similarity 210, member B | 20q13.2 | 0.218 | -0.244 | 3.47e-07
|
SAMD1 | sterile alpha motif domain containing 1 | 19p13.13 | 0.217 | 0.412 | 0
|
TCTEX1D2 | Tctex1 domain containing 2 | 3q29 | 0.217 | 0.351 | 1.06e-13
|
POLH | polymerase (DNA directed), eta | 6p21 | 0.216 | 0.254 | 1.15e-07
|
CSNK2A2 | casein kinase 2, alpha prime polypeptide | 16q21 | 0.215 | -0.264 | 3.35e-08
|
XK | X-linked Kx blood group | Xp21.1 | 0.215 | 0.191 | 7.08e-05
|
IL17RA | interleukin 17 receptor A | 22q11.1 | 0.213 | 0.066 | 0.175
|
TMEM107 | transmembrane protein 107 | 17p13.1 | 0.213 | 0.349 | 1.61e-13
|
FKBPL | FK506 binding protein like | 6p21.3 | 0.212 | 0.375 | 9.12e-16
|
SMTN | smoothelin | 22q12 | 0.212 | -0.194 | 5.6e-05
|
CISD2 | CDGSH iron sulfur domain 2 | 4q24 | 0.211 | 0.334 | 1.88e-12
|
BTN2A2 | butyrophilin, subfamily 2, member A2 | 6p22.1 | 0.21 | 0.271 | 1.51e-08
|
C12orf65 | chromosome 12 open reading frame 65 | 12q24.31 | 0.209 | 0.388 | 0
|
TCEAL6 | transcription elongation factor A (SII)-like 6 | Xq22.1 | 0.207 | -0.017 | 0.733
|
PHTF1 | putative homeodomain transcription factor 1 | 1p13.2 | 0.206 | 0.18 | 0.000196
|
ISPD | isoprenoid synthase domain containing | 7p21.2 | 0.206 | -0.186 | 0.000113
|
VWA7 | von Willebrand factor A domain containing 7 | 6p21 | 0.206 | 0.219 | 5.17e-06
|
EBPL | emopamil binding protein-like | 13q12-q13 | 0.205 | -0.249 | 2.02e-07
|
RUFY1 | RUN and FYVE domain containing 1 | 5q35.3 | 0.204 | -0.091 | 0.0607
|
ZNF277 | zinc finger protein 277 | 7q31.1 | 0.202 | -0.326 | 6.86e-12
|
RNF5P1 | ring finger protein 5, E3 ubiquitin protein ligase pseudogene 1 | 8p11.23 | 0.198 | 0.199 | 3.71e-05
|
ACO2 | aconitase 2, mitochondrial | 22q13.2 | 0.197 | -0.353 | 8.29e-14
|
BAG6 | BCL2-associated athanogene 6 | 6p21.3 | 0.195 | 0.287 | 1.78e-09
|
ST13P4 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 4 | 13q14 | 0.195 | -0.32 | 1.67e-11
|
PFN4 | profilin family, member 4 | 2p24.1 | 0.171 | 0.238 | 7e-07
|